Cytokinetics Inc. buy Barclays PLC
Start price
03.09.25
/
50%
€41.60
Target price
03.09.26
€61.04
Performance (%)
32.21%
Price
18:27
€55.00
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Cytokinetics Inc. has seen massive gains of 32.21%. This prediction currently runs until 03.09.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 1.887% | 1.887% |
| iShares Core DAX® | -3,52 % | -4,99 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % |
| iShares S&P 500 | -0,82 % | -0,04 % |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Barclays PLC from $53.00 to $71.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25
